Abstract

Human milk was always thought to have specific factors to protect infants from poliovirus, but it wasn’t until this landmark study that definitive antibodies to the virus were described both in the mother’s milk and serum.1 These investigators sampled the milk and sera of four women in the colostrum phase and four women on the thirteenth day postpartum, and identified anti-poliovirus antibody using neutralization assays and micro-immunodiffusion methods. Similar methods of radial immunodiffusion and enzyme-linked immunosorbent (ELISA) assays are still used today to identify antigen-specific antibodies in the milk after viral exposure. More specifically since the article 50 years ago, a functional relevance can be observed. Anti-influenza IgA in human milk can be identified by ELISA at a higher concentration with resultant fewer febrile illnesses in infants of women vaccinated with influenza vaccine during pregnancy compared to controls2; however, further study is needed to determine the exact mechanisms of human milk immunologic protection against these infectious diseases. New methods in the laboratory have recently been described by Lemay et al3 can determine pathways involved in the mammary gland by identifying the transcriptome in the milk fat globule. These remarkable findings will not just describe the milk properties but provide the opportunity to design interventional trials on the mother to influence milk production in beneficial ways for the infant.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call